Detalhe da pesquisa
1.
Recovery of cognitive function after relapse in multiple sclerosis.
Mult Scler
; 27(1): 71-78, 2021 01.
Artigo
Inglês
| MEDLINE | ID: mdl-31971066
2.
How to and should we target EBV in MS?
Expert Rev Clin Immunol
; : 1-12, 2024 Mar 15.
Artigo
Inglês
| MEDLINE | ID: mdl-38477887
3.
Neuroimaging assessment of facility-bound severely-affected MS reveals the critical role of cortical gray matter pathology: results from the CASA-MS case-controlled study.
J Neurol
; 2024 May 17.
Artigo
Inglês
| MEDLINE | ID: mdl-38758279
4.
Dynamic disability measures decrease the clinico-radiological gap in people with severely affected multiple sclerosis.
Mult Scler Relat Disord
; 87: 105630, 2024 Apr 22.
Artigo
Inglês
| MEDLINE | ID: mdl-38678969
5.
A decline in cognitive function should lead to a change in disease-modifying therapy - Yes.
Mult Scler
; 24(13): 1681-1682, 2018 11.
Artigo
Inglês
| MEDLINE | ID: mdl-30010476
6.
Tixagevimab and Cilgavimab (Evusheld™) Prophylaxis Prevents Breakthrough COVID-19 Infections in Immunosuppressed Population: 6-Month Prospective Study.
Vaccines (Basel)
; 11(2)2023 Feb 03.
Artigo
Inglês
| MEDLINE | ID: mdl-36851227
7.
Communicating the relevance of neurodegeneration and brain atrophy to multiple sclerosis patients: patient, provider and researcher perspectives.
J Neurol
; 270(2): 1095-1119, 2023 Feb.
Artigo
Inglês
| MEDLINE | ID: mdl-36376729
8.
Multiple Sclerosis in Children: Differential Diagnosis, Prognosis, and Disease-Modifying Treatment.
CNS Drugs
; 36(1): 45-59, 2022 01.
Artigo
Inglês
| MEDLINE | ID: mdl-34940954
9.
A prospective study to validate the expanded timed get-up-and-go in a population with multiple sclerosis.
Mult Scler J Exp Transl Clin
; 8(2): 20552173221099186, 2022.
Artigo
Inglês
| MEDLINE | ID: mdl-35571975
10.
COVID-19 Vaccination in Multiple Sclerosis and Inflammatory Diseases: Effects from Disease-Modifying Therapy, Long-Term Seroprevalence and Breakthrough Infections.
Vaccines (Basel)
; 10(5)2022 Apr 28.
Artigo
Inglês
| MEDLINE | ID: mdl-35632451
11.
Considering patient age when treating multiple sclerosis across the adult lifespan.
Expert Rev Neurother
; 21(3): 353-364, 2021 03.
Artigo
Inglês
| MEDLINE | ID: mdl-33595379
12.
Leptomeningeal, dura mater and meningeal vessel wall enhancements in multiple sclerosis.
Mult Scler Relat Disord
; 47: 102653, 2021 Jan.
Artigo
Inglês
| MEDLINE | ID: mdl-33333417
13.
Long-term drug treatment in multiple sclerosis: safety success and concerns.
Expert Opin Drug Saf
; 19(9): 1121-1142, 2020 Sep.
Artigo
Inglês
| MEDLINE | ID: mdl-32744073
14.
Late onset multiple sclerosis is associated with more severe ventricle expansion.
Mult Scler Relat Disord
; 46: 102588, 2020 Nov.
Artigo
Inglês
| MEDLINE | ID: mdl-33296984
15.
Bickerstaff brain stem encephalitis preceding recurrent myelin oligodendrocyte glycoprotein antibody-associated disease.
Acta Neurol Belg
; 2024 Mar 18.
Artigo
Inglês
| MEDLINE | ID: mdl-38498264
16.
Dimethyl Fumarate in the Treatment of Relapsing-Remitting Multiple Sclerosis: Patient Reported Outcomes and Perspectives.
Patient Relat Outcome Meas
; 10: 373-384, 2019.
Artigo
Inglês
| MEDLINE | ID: mdl-31849554
17.
Stress-full life events and multiple sclerosis: A population-based incident case-control study.
Mult Scler Relat Disord
; 26: 168-172, 2018 Nov.
Artigo
Inglês
| MEDLINE | ID: mdl-30268037
18.
Correction to: Communicating the relevance of neurodegeneration and brain atrophy to multiple sclerosis patients: patient, provider and researcher perspectives.
J Neurol
; 270(2): 1120-1126, 2023 Feb.
Artigo
Inglês
| MEDLINE | ID: mdl-36574066